Clinical milestones, product updates, team news – and encounters with the clinicians and survivors shaping what we build
We develop advanced neurotechnology solutions that support stroke recovery, helping patients regain movement, independence, and confidence in daily life.
Myonerv has secured a £100,000 Innovate UK Biomedical Catalyst Accelerator grant to run a 10-patient formative usability study, working in partnership with Health Innovation East.
Myonerv has achieved a world first: remotely triggering movement in the individual fingers of a user’s hand from over 2,000km away, in a live demonstration
Myonerv has been named to the 2026 #21toWatch Hall of Fame, recognising it as one of the East of England’s most promising startups. Companies honoured
Myonerv has been selected as one of ten founders on a new UK Hospital/Community HealthTech Accelerator, backed by Innovate UK, supporting startups working to shift
Myonerv took 1st place at RESI London 2025, winning an innovators’ pitching challenge among a strong field of life sciences and health tech companies. The
Myonerv has been awarded a £65,000 Innovate UK grant to further advance the electronics behind its wearable neurorehabilitation device, working in partnership with the Manufacturing
Myonerv took 1st place at the Wireless Innovation Forum 2025, winning an innovators’ pitching challenge held in front of a network spanning 6 NHS Trusts,
Myonerv was highlighted at the 8th International Cambridge Neuroscience Symposium as a next-generation neurotechnology working to improve recovery outcomes for stroke patients. The symposium brought
Myonerv Founder and CEO Sam Kamali has been awarded a £120,000 Cambridge NeuroWorks Fellowship, backed by ARIA (the UK’s Advanced Research and Invention Agency), to
Myonerv was named runner-up in the Start-Up category at the 2025 SEHTA (Science & Engineering Health Technologies Alliance) Healthcare Business Awards, held on 10 April
Myonerv was showcased at The British Museum as part of the SXUK24 event, bringing the company’s wearable neurorehabilitation technology into one of the world’s most
We are incredibly proud to announce that Myonerv was recently named a Finalist at the Santander X UK Awards 2024, securing a £2,500 prize and